Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1020
-0.0035 (-3.32%)
At close: Mar 27, 2026
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 67.48 million as of March 27, 2026. Its market cap has decreased by -5.92% in one year.
Market Cap
67.48M
Enterprise Value
37.81M
Revenue
4.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 67.48M, an increase of 45.30%. That is a compound annual growth rate of 2.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 67.48M | -12.45% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 98.12M |
| Scandinavian ChemoTech AB | 96.73M |
| Alzinova AB | 91.12M |
| Biosergen AB | 85.01M |
| Magle Chemoswed Holding AB | 81.77M |